Minnow Street Minnow Street
Buy Day today: Poor Neutral (49) Good Mixed market breadth · no major macro event

Chiron Real Estate Inc. (XRN)

Real Estate REIT - Healthcare Facilities
37.00 $
Closing price · As of: 20. Jul 2026
🔔 Watch stock

Appears in These Scanners

This stock currently matches 7 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Basics

Market Cap
0.0Mrd. $
Shares Outstanding
13Mio.
Float
93.0%
Beta
1.1

Performance

Perf. 1M
3.20%
Perf. 3M
18.50%
Perf. 6M
15.80%
YTD Performance (%)
8.80%
52-Week-High Distance
-9.5%

Valuation

P/E
Forward P/E
250.0
PEG
5.1
P/B
P/S
EV/EBITDA
15.6
Price/FCF

Profitability

Gross Margin
100.0%
EBIT Margin
Net Margin
-5.1%
Return on Equity
-1.7%
Return on Assets
1.8%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
Altman Z
-0.39
Piotroski
6 von 9

Growth

Sales Growth Last Quarter
0.00%
EPS Growth Last Quarter
Sales Growth (Year)
16.34%
Forward Sales Growth
-0.92%
Forward EPS Growth
-2.00%

Dividend

Dividend Yield
15.09%
Dividend Per Share (TTM)
2.41$
Payout Ratio
1,114.3%
Years Without a Cut
0Years
Increase Streak
0Years

Quality & Screener

Stage
2
RS Rating
47
EPS Rating
50
Piotroski
6 von 9
Fundamental Rating
D (-40 von 100)
Altman Z
-0.39

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Sales Per Quarter ($M)
2024: Q4 · 35.0 Mio. $ Q4 2025: Q1 · 37.9 Mio. $ Q1 2025: Q2 · 41.3 Mio. $ Q2 2025: Q3 · 40.6 Mio. $ Q3 2025: Q4 · 38.4 Mio. $ Q4 2026: Q1 · 38.1 Mio. $ Q1
Earnings Per Share Per Quarter ($)
2024: Q4 · 0.21 $ Q4 2025: Q1 · 0.27 $ Q1 2025: Q2 · 0.05 $ Q2 2025: Q3 · -0.34 $ Q3 2025: Q4 · -0.41 $ Q4 2026: Q1 · 0.13 $ Q1
Net Margin Per Quarter (%)
2024: Q4 · 8.1 % Q4 2025: Q1 · 9.4 % Q1 2025: Q2 · 1.6 % Q2 2025: Q3 · -11.2 % Q3 2025: Q4 · -14.3 % Q4 2026: Q1 · 4.5 % Q1
Operating Cash Flow Per Quarter ($M)
2024: Q4 · 20.5 Mio. $ Q4 2025: Q1 · 12.3 Mio. $ Q1 2025: Q2 · 22.1 Mio. $ Q2 2025: Q3 · 17.6 Mio. $ Q3 2025: Q4 · 21.6 Mio. $ Q4 2026: Q1 · 13.4 Mio. $ Q1
Free Cash Flow Per Quarter ($M)
2024: Q4 · -33.3 Mio. $ Q4 2025: Q1 · 12.3 Mio. $ Q1 2025: Q2 · 22.1 Mio. $ Q2 2025: Q3 · 17.6 Mio. $ Q3 2025: Q4 · 18.3 Mio. $ Q4 2026: Q1 · 11.2 Mio. $ Q1
Sales Growth vs. Year-Ago Quarter (%)
2025: Q3 · 18.7 % Q3 2025: Q4 · 9.8 % Q4 2026: Q1 · 0.5 % Q1
EPS Growth vs. Year-Ago Quarter (%)
2025: Q3 · -239.7 % Q3 2025: Q4 · -294.5 % Q4 2026: Q1 · -51.0 % Q1
Price Change in Quarter (%)
2024: Q4 · -20.0 % Q4 2025: Q1 · 16.1 % Q1 2025: Q2 · -18.8 % Q2 2025: Q3 · -0.5 % Q3 2025: Q4 · 2.3 % Q4 2026: Q1 · -1.2 % Q1

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.21 35 8.10 21 -33
2025: Q1 0.27 38 9.40 12 12
2025: Q2 0.05 41 1.60 22 22
2025: Q3 -0.34 -239.70 41 18.70 -11.20 18 18
2025: Q4 -0.41 -294.50 38 9.80 -14.30 22 18
2026: Q1 0.13 -51.00 38 0.50 4.50 13 11
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Employees30
HeadquartersBethesda, MD
Websitechironre.com
IPO Date29. Jun 2016
Next Earnings4. Aug 2026

Management

Management
Name Title Birth Year
Mark O. Decker Jr. President, CEO & Director 1976
Robert J. Kiernan CPA CFO & Treasurer 1966
Danica C. Holley Chief Operating Officer 1973
Alfonzo Leon Chief Investment Officer 1976
Jamie A. Barber J.D. General Counsel & Corporate Secretary 1977
Michael Farinawicz Senior Vice President of Strategy & Investor Relations
Ray Braun Managing Director
Randy Haugh Senior Vice President of Finance
Sally Tseng Controller
Stephen C. Swett Investor Relations Executive

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?